key: cord-0015035-u9f535zb authors: Bokhary, Hamid; Pangesti, Krisna N. A.; Rashid, Harunor; Abd El Ghany, Moataz; Hill-Cawthorne, Grant A. title: Travel-Related Antimicrobial Resistance: A Systematic Review date: 2021-01-16 journal: Trop Med Infect Dis DOI: 10.3390/tropicalmed6010011 sha: ff7f67e28d68f2446834e0b2e7b3f79fd1115329 doc_id: 15035 cord_uid: u9f535zb There is increasing evidence that human movement facilitates the global spread of resistant bacteria and antimicrobial resistance (AMR) genes. We systematically reviewed the literature on the impact of travel on the dissemination of AMR. We searched the databases Medline, EMBASE and SCOPUS from database inception until the end of June 2019. Of the 3052 titles identified, 2253 articles passed the initial screening, of which 238 met the inclusion criteria. The studies covered 30,060 drug-resistant isolates from 26 identified bacterial species. Most were enteric, accounting for 65% of the identified species and 92% of all documented isolates. High-income countries were more likely to be recipient nations for AMR originating from middle- and low-income countries. The most common origin of travellers with resistant bacteria was Asia, covering 36% of the total isolates. Beta-lactams and quinolones were the most documented drug-resistant organisms, accounting for 35% and 31% of the overall drug resistance, respectively. Medical tourism was twice as likely to be associated with multidrug-resistant organisms than general travel. International travel is a vehicle for the transmission of antimicrobial resistance globally. Health systems should identify recent travellers to ensure that adequate precautions are taken. Antimicrobial resistance (AMR) is a growing public health burden that is a serious threat to global health security [1] . The World Health Organization (WHO) has emphasised the broad impact that AMR will have on human lives, including on health, economic prosperity and other livelihoods [2] . A number of reports have now highlighted the substantially increased levels of AMR bacteria present in many regions of the world [2, 3] . For example, the US Centers for Disease Control and Prevention (CDC) have estimated that there are around 2 million infectious cases in the US annually that are resistant to at least one antimicrobial, resulting in about 23,000 deaths and costing the US health system US$20-$35 billion [4] . Importantly, it has been estimated that this increase in the emergence of AMR organisms can also increase the morbidity and mortality of infectious diseases, as it hampers the ability of antimicrobial drugs to cure infections [3, 5] . AMR infections currently result in 700,000 global deaths every year, with associated mortality estimated to Studies and reports were identified by searching electronic databases, including Medline (PubMed and Ovid), Embase and Scopus, from database inception to the end of June 2019. The search results are presented as per the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines [28] in Figure 1 . We used a combination of key words including: "travel" OR "pilgrim*" OR "Hajj" (also alternative spellings "Hadj" or "Haj") OR "Olympic" OR "overseas student" OR "international student" OR "immigrant" OR "world cup" OR "mass gathering" OR "crowding" OR "tourism" OR "travel medicine" OR "holiday" AND "drug resistance" OR "methicillinresistant Staphylococcus aureus" OR "antimicrobial resistan*". In addition, a manual search was performed on the reference lists of included studies to identify additional potentially relevant papers. Studies that were non-English (language), nonbacterial (organism) or nonhuman (host) were excluded. After screening, studies that did not address travel and AMR were excluded. In addition, studies that had the same or partially the same population with duplicated isolates were included [29] [30] [31] [32] (but have had their isolates numbers adjusted) or completely removed [33, 34] (if there was true duplication to the isolate profiles). Isolates were included if there was no duplication of information [35, 36] . Reviews, editorials, comments and other non-observational articles were also excluded. Initially, the intent was to include all contexts of human movement. While developing the manuscript, other systematic reviews were published for some human movement contexts, such as refugees and Hajj [19, 37] ; therefore, studies with these special contexts of human movement were excluded: asylum seekers, immigrants, refugees, non-local adoption and mass-gathering attendees. Non-randomised studies were assessed based on the Newcastle-Ottawa Scale (NOS) [38] for cohort and case-control studies. Cross-sectional studies and surveys were assessed with an adapted version of NOS that was used previously by Modesti and colleagues [39] . Moreover, case reports and case series were assessed using a NOS-adapted method that was described by Murad and colleagues [40] . Assessment was based on the respective scoring system, thus setting the maximum score to 9 for cohort and case-control assessments, 10 for cross-sectional studies and surveys, and 5-8 (depending on the study) for case reports and case series article assessment. A grade of "A" was given to randomised control trials (RCTs) of adequate sample size, and it was graded as "B" if the sample size was not adequate. Regarding observational and non-randomised studies, grade "A" was Studies that were non-English (language), nonbacterial (organism) or nonhuman (host) were excluded. After screening, studies that did not address travel and AMR were excluded. In addition, studies that had the same or partially the same population with duplicated isolates were included [29] [30] [31] [32] (but have had their isolates numbers adjusted) or completely removed [33, 34] (if there was true duplication to the isolate profiles). Isolates were included if there was no duplication of information [35, 36] . Reviews, editorials, comments and other non-observational articles were also excluded. Initially, the intent was to include all contexts of human movement. While developing the manuscript, other systematic reviews were published for some human movement contexts, such as refugees and Hajj [19, 37] ; therefore, studies with these special contexts of human movement were excluded: asylum seekers, immigrants, refugees, non-local adoption and mass-gathering attendees. Non-randomised studies were assessed based on the Newcastle-Ottawa Scale (NOS) [38] for cohort and case-control studies. Cross-sectional studies and surveys were assessed with an adapted version of NOS that was used previously by Modesti and colleagues [39] . Moreover, case reports and case series were assessed using a NOS-adapted method that was described by Murad and colleagues [40] . Assessment was based on the respective scoring system, thus setting the maximum score to 9 for cohort and case-control assessments, 10 for cross-sectional studies and surveys, and 5-8 (depending on the study) for case reports and case series article assessment. A grade of "A" was given to randomised control trials (RCTs) of adequate sample size, and it was graded as "B" if the sample size was not adequate. Regarding observational and non-randomised studies, grade "A" was given for 75% or above (in reference to the maximum score), "B" was given for 50-74% and "C" was given for less than a 50% score on a NOS-based or adapted assessment. The total number of studies identified from the nominated databases was 3719 articles, of which 667 were duplicates. By skimming the titles, 799 articles were excluded for not being in English or because they focused on other non-bacterial organisms or on zoonotic hosts. The remaining 2253 articles were screened via their abstracts. Excluding nonobservational studies and studies not addressing travel and AMR resulted in 326 eligible studies. The decision to exclude the aforementioned special types of human movement yielded the final 238 studies that were included in this analysis. All phenotypic and molecular confirmations for the acquisition of AMR during travel documented in these studies were included in the analysis. Figures were created using template mapchart.net (https://mapchart.net/), which are licensed under the "Creative Commons Attribution-ShareAlike 4.0 International License" (https://creativecommons.org/licenses/by-sa/4.0/). A total of 30,060 AMR bacterial isolates associated with 17,470 instances of planned international travel (at least one AMR organism documented per instance) was documented in the 238 studies [27, [29] [30] [31] [32] [33] 35, 36, included in this analysis (Table 1) . Most studies reported the detection of at least one AMR bacterial species after travel, while travelling or prior to the commencement of travel. There were 2 RCTs, 2 cohort, 13 case-control, 155 cross-sectional (or survey) and 66 case report/series study types. Regarding study assessment, there were 29 studies scored as grade A, 92 scored as B and 177 scored as C based on NOS or assessments adapted from it (Table 1) . The total pooled population of travellers screened was 632,704, of which 26.33% (n = 166,615) were female and the gender was not documented in 38.22% (241, 829) . The average representative age of case patients from the pooled studies, when available, was 38.9 years (range 0-103.2 years). A subpopulation of travellers experienced exposure to healthcare systems whilst travelling: hospitalised in, admitted to, repatriated from or seeking treatment (such as medical tourists) from healthcare facilities. Of these 11,089 "medical travellers", 23.09% (n = 2560) were female and the gender was not documented in 52.51% (n = 5823). The average representative age for medical travellers was 51.4 years (range 0-99 years). The analysis demonstrated that AMR organisms originated from 139 countries and travelled to 34 countries in total. In general, low-and middle-income countries (124 out The countries and regions given in the articles included in the analysis were categorised into 11 groups according to their geographical locations (Table S2 ). The top regions from which the majority of AMR organisms were sourced or to which people travelled are provided in Tables S3 and S4, The identified resistant organisms comprised 26 bacterial species that mostly included Gram-negative bacteria (e.g., Escherichia coli and Salmonella spp.) and other bacterial species that are commonly associated with hospital-(e.g., Staphylococcus aureus and Acinetobacter baumanii) or community-acquired infections (Table S5 ). The bacterial species were not spec- Many of the drug groups for which resistance was reported are clinically important. Resistance to quinolones was documented in 9213 isolates, that to sulphonamides and trimethoprim was documented in 7268 isolates and that to cephalosporins was documented in 2100 isolates (Table S6 ). Resistance to beta-lactams was seen in 10,474 isolates, which includes resistance to penicillins in 6320 isolates and to carbapenems in 1922 isolates. This means that many of the AMR bacteria detected include species on the WHO list priority pathogen list of bacteria that pose the greatest threat to human health and resistance to critically important antibiotics [2]. These include carbapenem-resistant and extendedspectrum beta-lactamase (ESBL) producers of various Enterobacteriaceae members (e.g., E. coli and Klebsiella spp.), methicillin-resistant S. aureus (MRSA), and fluoroquinoloneresistant Salmonella spp. and Campylobacter spp. Some of the organisms on the WHO list could be detected over a number of decades, with Table 2 listing the detection rates of these nominated organisms by time period and location. 3 Includes 610 isolates with a broad isolation time frame, 1984-2015; AMR: antimicrobial resistance; All AMR: the total number of isolates with any reported AMR; CP: carbapenem resistance, not exclusive from beta-lactam resistance; BL: beta-lactam resistance, includes carbapenem and/or cephalosporin resistance; MDR: multidrug-resistant organisms, organisms documented as multidrug-resistant, or resistant to three or more classes of antimicrobials; MRSA: methicillin-resistant Staphylococcus aureus; QR: quinolone resistant, may include co-resistance with beta-lactams or methicillin; Other: unspecified or multiple regions were documented. Some bacterial species have been the focus of previous studies on travel-related infections. However, some of these species were only occasionally detected in this study, including Mycobacterium spp. (n = 91; 5 studies), Neisseria gonorrhoeae (n = 120; 3 studies), Pseudomonas spp. (n = 44; 12 studies), Burkholderia pseudomallei (n = 5; 5 studies), or those that can cause epidemics (e.g., Vibrio cholerae (n = 5; 3 studies)) (Table S5) . Nearly all AMR M. tuberculosis (n = 88; 4 studies) that were associated with travel originated from Africa and are resistant to both isoniazid and rifampicin (n = 86; 2 studies). Travel-associated AMR B. pseudomallei infections were sporadic, with the cases reported usually associated with travel to tropical areas. All travel-related AMR N. gonorrheae isolates were resistant to ciprofloxacin (n = 119; 2 studies). Of the recorded AMR movements associated with travel, 91.83% (n = 27,593; 195 studies) were of enteric bacteria, of which the species was not identified in 18.85% (n = 5200). Of these unidentified enteric bacteria, 2448 were recorded between 1990 and 1999 (47.08%), 415 were recorded between 2000 and 2009 (7.98%), 2337 were recorded between 2010 and 2019 (44.75%), and none were recorded before 1990; the movements of these unidentified enteric bacteria are illustrated in Figure 2 . A gradual increase was seen in the number of AMR enteric bacteria overall over time, from 1074 before 1990 (3.89%) to 6427 (1990-1999; 23.29%) and 15,067 AMR enteric bacteria (2000-2009; 54.60%). The majority of these AMR enteric bacteria were associated with travel originating from Asia (35.24%, n = 9725; excluding West Asia), and Central and South America (13.13%, n = 3623). Interestingly, 14.91% (n = 4113; 102 studies) of enteric bacteria associated with travel were categorised as multidrug-resistant (MDR, resistance to three or more antimicrobial classes). The AMR profiles for 37.66% (n = 1549) of MDR enteric bacteria associated with travel were available; 68.11% of MDR enteric bacteria (n = 1055) were resistant to beta-lactams (including carbapenems and cephalosporins) and sulphonamides (including trimethoprim), of which 32.99% (n = 348), 25.78% (n = 272) and 29.38% (n = 310) were co-resistant with amphenicols, quinolones or both, respectively. Some bacterial species have been the focus of previous studies on travel-related infections. However, some of these species were only occasionally detected in this study, including Mycobacterium spp. (n = 91; 5 studies), Neisseria gonorrhoeae (n = 120; 3 studies), Pseudomonas spp. (n = 44; 12 studies), Burkholderia pseudomallei (n = 5; 5 studies), or those that can cause epidemics (e.g., Vibrio cholerae (n = 5; 3 studies)) (Table S5) . Nearly all AMR M. tuberculosis (n = 88; 4 studies) that were associated with travel originated from Africa and are resistant to both isoniazid and rifampicin (n = 86; 2 studies). Travel-associated AMR B. pseudomallei infections were sporadic, with the cases reported usually associated with travel to tropical areas. All travel-related AMR N. gonorrheae isolates were resistant to ciprofloxacin (n = 119; 2 studies). Of the recorded AMR movements associated with travel, 91.83% (n = 27,593; 195 studies) were of enteric bacteria, of which the species was not identified in 18.85% (n = 5200). Of these unidentified enteric bacteria, 2448 were recorded between 1990 and 1999 (47.08%), 415 were recorded between 2000 and 2009 (7.98%), 2,337 were recorded between 2010 and 2019 (44.75%), and none were recorded before 1990; the movements of these unidentified enteric bacteria are illustrated in Figure 2 . A gradual increase was seen in the number of AMR enteric bacteria overall over time, from 1074 before 1990 (3.89%) to 6,427 (1990-1999; 23 .29%) and 15,067 AMR enteric bacteria (2000-2009; 54.60%). The majority of these AMR enteric bacteria were associated with travel originating from Asia (35.24%, n = 9725; excluding West Asia), and Central and South America (13.13%, n = 3,623). Interestingly, 14.91% (n= 4113; 102 studies) of enteric bacteria associated with travel were categorised as multidrug-resistant (MDR, resistance to three or more antimicrobial classes). The AMR profiles for 37.66% (n = 1,549) of MDR enteric bacteria associated with travel were available; 68.11% of MDR enteric bacteria (n = 1055) were resistant to beta-lactams (including carbapenems and cephalosporins) and sulphonamides (including trimethoprim), of which 32.99% (n = 348), 25.78% (n = 272) and 29.38% (n = 310) were co-resistant with amphenicols, quinolones or both, respectively. Figure 6 . Table 2 ). The majority of any AMR-or quinolone-resistant Campylobacter spp. originated from Asia (n = 752 or n = 627, 23.00% or 24.39% respectively; excluding West Asia). Travel-associated AMR Klebsiella pneumoniae numbers documented in the literature were low in relation to the corresponding number of studies (n = 187; 27 studies) when compared with other organisms (Table S5) (Table 2) . While the countries of origin were not specified for 56.68% (n = 106) of isolates, the most documented source was Asia (except West Asia): n = 31, 16 and 14 for any AMR, MDR and carbapenem-resistant K. pneumoniae, respectively. The movements of K. pneumoniae isolates associated with travel are illustrated in Figure S1 . The total number of AMR bacteria isolated from medical travellers was 1342 (49 studies). Beta-lactam resistance (including carbapenem and cephalosporin resistance) was Table 2 ). The majority of any AMRor quinolone-resistant Campylobacter spp. originated from Asia (n = 752 or n = 627, 23.00% or 24.39% respectively; excluding West Asia). Travel-associated AMR Klebsiella pneumoniae numbers documented in the literature were low in relation to the corresponding number of studies (n = 187; 27 studies) when compared with other organisms (Table S5) . Interestingly, no documentation of AMR K. pneumoniae is present before 2000. Resistant K. pneumoniae numbers increased in the following two decades: with 25 and 57 MDR isolates detected in 2000-2009 (28.74%) and 2010-2019 (65.52%), respectively, and three and 26 carbapenem-resistant K. pneumoniae isolates detected (10.34% and 89.66%), respectively (Table 2) . While the countries of origin were not specified for 56.68% (n = 106) of isolates, the most documented source was Asia (except West Asia): n = 31, 16 and 14 for any AMR, MDR and carbapenem-resistant K. pneumoniae, respectively. The movements of K. pneumoniae isolates associated with travel are illustrated in Figure S1 . The total number of AMR bacteria isolated from medical travellers was 1342 (49 studies). Beta-lactam resistance (including carbapenem and cephalosporin resistance) was identified in 64.01% (n = 859; 24 studies) of AMR bacteria associated with medical travellers. Moreover, 6.33% (n = 85; 5 studies) of bacterial isolates from medical travellers were quinolone-resistant, of which 29.41% of these (n = 24; 3 studies) were beta-lactam co-resistant. Interestingly, MDR organisms comprised 24.14% (n = 324; 32 studies) of medical traveller bacterial isolates. Hence, medical travellers have around twice the odds of detecting MDR bacterial isolates than other travellers (OR = 1.99, p < 0.001; considering all isolates are independent observations). Nearly all of the AMR strains of A. baumannii (n = 150; 19 studies) and Pseudomonas aeruginosa (n = 43; 11 studies) that were reported in the analysed articles were associated with medical travellers; 26.00% (n = 39) of A. baumannii strains were categorised as MDR, of which 46.15% (n = 18) showed resistance to the combination of beta-lactams, quinolones and aminoglycosides and 33.33% (n = 50) were categorised as beta-lactam-resistant (all were carbapenem-resistant); and 34.88% (n = 15) of the P. aeruginosa strains were categorised as MDR, of which 53.33% (n = 8) showed resistance to the combination of beta-lactams, quinolones and aminoglycosides and 34.88% (n = 15) were categorised as beta-lactam resistant (all were carbapenem-and/or cephalosporin-resistant). Moreover, medical Nearly all of the AMR strains of A. baumannii (n = 150; 19 studies) and Pseudomonas aeruginosa (n = 43; 11 studies) that were reported in the analysed articles were associated with medical travellers; 26.00% (n = 39) of A. baumannii strains were categorised as MDR, of which 46.15% (n = 18) showed resistance to the combination of beta-lactams, quinolones and aminoglycosides and 33.33% (n = 50) were categorised as beta-lactam-resistant (all were carbapenem-resistant); and 34.88% (n = 15) of the P. aeruginosa strains were categorised as MDR, of which 53.33% (n = 8) showed resistance to the combination of beta-lactams, quinolones and aminoglycosides and 34.88% (n = 15) were categorised as beta-lactam resistant (all were carbapenem-and/or cephalosporin-resistant). Moreover, medical travellers with P. aeruginosa infections usually stayed longer in hospitals when they returned, with a mean hospital length of stay of over 45 days [80] . Furthermore, studies documented that P. aeruginosa with the bla NDM-1 resistance gene were first identified in North America and Europe from medical travellers arriving from Asia and Europe, respectively [103, 173] . Antimicrobial resistance has become a major global health emergency, with human displacement [271] , such as that seen for refugees or travellers, as a facilitative factor [19, 20] . While the link between AMR and travel was explored previously, few studies have examined this over time and across different regions of the world [6] . Here, we have compiled and analysed the literature recording the detection of travel-related AMR bacteria during the past three decades. Prior to 1990, a few studies noted a small number of AMR bacteria being isolated, with the most frequently recorded being Shigella spp. from Central and South America or an unspecified location, detected in four studies with 641 isolates. Over time, the frequency of detection of AMR bacteria has increased; however, the number of studies performed has also increased, as has the ease of resistance testing. However, it is clear that there is increasing detection of quinolone-resistant Campylobacter spp., MDR Shigella spp., quinolone-resistant Salmonella spp., and ESBL-producing and quinolone-resistant E. coli isolates. Examining the trends over time and the geographic regions from which AMR appears to be emerging can help inform on how we should be treating travellers returning from these at-risk regions. From our results, we can see that quinolone resistance in Shigella spp. was first detected in travellers returning from Oceania before 1990 and Asia between 1990-1999. During the same time period, quinolone-resistant Salmonella spp. was also being seen in travellers returning from Asia, with a definite spike in quinolone-resistant and MDR cases of Salmonella between 2000 and 2009. While MDR Shigella spp. was also seen in travellers returning from Asia in 1990-1999, a number of isolates were also associated with West Asia, and North Africa and Europe, with a more distributed picture occurring between 2000 and 2009. Gastrointestinal (GI) infections or complaints are commonly associated with travel [272] . Diarrhoea is the most common GI symptom associated with travel and is seen in around 60% of GI cases [273] . Travellers' diarrhoea occurs less frequently with travel from economically developed countries compared with other countries, and bacteria are the most common microbiologically identified aetiology [273, 274] . Unsurprisingly, in our study, enteric bacteria also make up the most frequently occurring AMR species associated with travel. Of particular concern is that AMR enteric bacteria, when acting as either a pathogen or coloniser, can transfer their resistance elements to other commensal or pathogenic bacteria present in the gut [275] . We have found that the number of enteric bacterial isolates that are resistant to antibiotics has been increasing over the years, with quinolone resistance in particular being seen more frequently. The WHO raised international concerns over fluoroquinolone-resistant enteric bacteria in their 2014 report [2] . Also echoed in the WHO report is the growing frequency with which MRSA as well as carbapenemase-and ESBLproducing Klebsiella pneumoniae are detected in travellers [6] . As many of the travel-related quinolone-resistant enteric bacteria originated from Asia, we suggest that clinicians who see travellers from this region with GI-related illnesses should avoid empirically prescribing ciprofloxacin or any other quinolones. The best course of treatment for returning travellers who complain of GI symptoms suggesting a bacterial aetiology should now be considered. Based on practical observations from our data, we would caution against or avoid empirical treatment with beta-lactams and quinolones for bacterial GI travel-related illnesses until an AMR profile or culture and sensitivity testing has been performed. For severe cases with a history of travel to Asia, empirical treatment could start with azithromycin (which was also suggested by other studies [272] ) and then change to the drug of choice once the AMR results are back. For travellers returning from other destinations, chloramphenicol could also be used as there are still a low number of documented resistant cases globally (Table S7) . For travellers arriving from Africa, Central America or South America, it is advisable to avoid prescribing sulphonamides and trimethoprim due to the high levels of resistance seen in bacteria from these regions. Other general guides for returning travellers with bacterial GI infections include setting and related translational medicine evaluation and implementation [272] . Medical travel-related AMR produces a significant risk that resistance may be introduced to a specific part of a health system or even into a complete health system [276] . Some studies mentioned that medical travel-related AMR isolates cause outbreaks within their receiving institutes [88, 268] and suggested protocols for such scenarios [47] . There is a lack of documentation for developing economies' health systems on how they should prepare when receiving such patients. In addition, monitoring medical-related AMR is challenging, as medical tourism has been increasing in frequency, with associated complications often not being reported as linked to travel [277] . There are a number of limitations with this retrospective systematic review. There is significant variation in the ways in which bacterial species are identified (whether via traditional isolation or PCR) and then undergo antimicrobial susceptibility testing. Often, studies do not clearly link isolates or bacterial species to AMR profiles, and such data are not included as Supplementary Information. Travel histories can be vague and incomplete and are often limited to the destination country because this is the one in which the study is performed, with the origin country being that of most recent travel. This reflects the, often retrospective, nature of the studies and clearly does not have pre-and post-travel samples with a clear itinerary in between, limiting the usefulness and precision of these data. AMR bacteria acquired through travel are also not just a risk for the traveller; some isolates may be detected in family members or other close contacts. Finally, MDR bacteria were properly characterised in the majority of studies (n = 101; 1745 isolates) included in our analysis. In a few studies (n = 16 studies; 2440 isolates), the authors identified MDR bacteria based on the number of clinically relevant antibiotics (at least three) to which these isolates exhibited resistance without specifying these drugs. A major source of bias in this study is the country in which it was carried out. The majority of cases of travel-related AMR were presented in someone travelling to an economically developing region of the world and then returning to their home country (usually economically developed), being the location where they both fell ill and attended facilities available for testing. The majority of global travel is within-country rather than interregional. For example, in 2018, in the USA, domestic air travellers were 3.3-fold more common than international travellers [278] . This means that our findings are necessarily skewed towards developing countries being the origin and developed countries being the destination for AMR bacteria. This is unsurprising as the United Nations Educational, Scientific and Cultural Organization (UNESCO) has found that, between 1996-2015, countries with developed economics spend an average of 1.5% of their GDP on research and development, while countries with economies in transition and countries with developing economies only spend 0.6% of their GDP on research and development [279] . The disproportionate number of studies within different regions therefore limits our understanding of the global picture of travel-related AMR. More efforts should focus on the global impacts of travel-related AMR and to encourage studies originating from developing countries. Establishing enteric bacterial AMR profiles for regions with the most traffic to or from may help other healthcare systems address a major part of travel-related AMR. To allow accurate prescription of antimicrobials for patients with complaints that are suspected to be travel-related, hospitalised and inter-healthcare transfers need to be managed in the same way as tertiary-care referrals, with preventive methods on both sides of the journey. Similarly, health authorities may consider the implementation of new guidelines or restrictions for travellers suffering from bacterial infections or those under antibiotic treatment. Supplementary Materials: The following are available online at https://www.mdpi.com/2414-636 6/6/1/11/s1, Figure S1 . Travel-related antimicrobial resistant Klebsiella pneumoniae movements, 2000-2019, Table S1. List of the included studies in the review, Table S2 . List of Countries or regions that are documented in the review, Table S3 . Top originating regions for AMR organisms (source), Table S4 . Top destination regions for AMR organisms (destination), Table S5 . Number of studies and isolates for species that were documented in the analyzed studies, Table S6 . Numbers of travelrelated AMR isolates documented in 238 studies, up to June 2019 inclusive, categorized by source and isolation time, Table S7 . Number of travel-related isolates for enteric organisms with documented AMR component, Table S8 . Antimicrobials categories that were included in the analysis. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance Antibiotic Resistance Threats in the United States Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations Understanding the mechanisms and drivers of antimicrobial resistance Abd El Ghany, M. The Contribution of Wastewater to the Transmission of Antimicrobial Resistance in the Environment: Implications of Mass Gathering Settings Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae Antimicrobial Medicines Consumption in Eastern Europeand Central Asia-An Updated Cross-National Study and Assessment of Quantitative Metrics for Policy Action The Evaluation of Antibiotic Consumption at the Inpatient Level in Kazakhstan from Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. Front Evolution of the Serbian pharmaceutical market alongside socioeconomic transition Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals World Tourism Organization. UNWTO World Tourism Barometer and Statistical Annex Infectious risks of medical tourism United Nations High Commissioner for Refugees Refugees and antimicrobial resistance: A systematic review Antibiotic Resistance in Syria: A Local Problem Turns into a Global Threat Population aging and migration-History and UN forecasts in the EU-28 and its east and south near neighborhood-One century perspective 1950-2050 Urbanisation and infectious diseases in a globalised world Group a meningococcal carriage in travelers returning from Saudi Arabia Evidence for several waves of global transmission in the seventh cholera pandemic Ending Cholera A Global Roadmap to 2030; World Health Organization Meningococcal disease during the Hajj and Umrah mass gatherings Import and spread of extended-spectrum b-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): A prospective, multicentre cohort study Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus Import of community-associated, methicillin-resistant Staphylococcus aureus to Europe through skin and soft-tissue infection in intercontinental travellers Colonisation with Escherichia coli resistant to "critically important" antibiotics: A high risk for international travellers Prolonged carriage of resistant E. coli by returned travellers: Clonality, risk factors and bacterial characteristics Variation in the genetic environments of bla CTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK Emergence of drug resistant bacteria at the Hajj: A systematic review The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses The European Society of Hypertension Working Group on Cardiovascular Risk in Low Resource Settings. Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis Methodological quality and synthesis of case series and case reports Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: Antimicrobial resistance on the rise Ovarian endometrioma superinfected with Salmonella: Case report and review of the literature. Open Forum Infect Genetic environment of the bla KPC-2 gene in a Klebsiella pneumoniae isolate that may have been imported to Russia from Southeast Asia Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg Enteric Fever in a Tertiary Paediatric Hospital: A Retrospective Six-Year Review Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines Outbreak of Shigella sonnei in a rural hotel Escherichia coli O104:H4 infections and international travel Outbreak of a South West Pacific clone Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus infection in a UK neonatal intensive care unit Delayed diagnosis of high drug-resistant microorganisms carriage in repatriated patients: Three cases in a French intensive care unit Medical evacuation from abroad of critically ill patients: A case report and ethical issues Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections Risk Factors for Colonization with Multidrug-Resistant Bacteria Among Patients Admitted to the Intensive Care Unit After Returning From Abroad Epidemiological evidence of multidrug-resistant Shigella sonnei colonization in India by sentinel surveillance in a Japanese quarantine station Recurrent furunculosis in returning travelers: Newly defined entity Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: A cross-sectional study Travel-associated antimicrobial drug-resistant nontyphoidal Salmonellae Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt The Human Gut Microbiome as a Transporter of Antibiotic Resistance Genes between Continents Travelers can import colistin-resistant Enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: Molecular epidemiology 2004-2014 Community-acquired methicillin-resistant Staphylococcus aureus infections in two scuba divers returning from the Philippines Mycotic aneurysm caused by Burkholderia pseudomallei in a previously healthy returning traveller Epidemiology and outcome of Shigella, Salmonella and Campylobacter infections in travellers returning from the tropics with fever and diarrhoea Etiology of acute diarrhea among United States military personnel deployed to South America and west Africa Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin-United States Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp CTX-M-65 Extended-Spectrum b-Lactamase-Producing Salmonella enterica Serotype Infantis, United States Mechanism of resistance to several antimicrobial agents in Salmonella clinical isolates causing traveler's diarrhea Characterization of the enzyme aac(3)-id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea. Enfermedades Infecciosas y Microbiologia Clinica Ciprofloxacin resistance in Campylobacter jejuni: Case-case analysis as a tool for elucidating risks at home and abroad Genetic diversity of Campylobacter jejuni isolates from Korea and travel-associated cases from east and southeast Asian countries The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan-United States Methicillin-resistant Staphylococcus aureus infections in Uppsala County The growing burden of multidrugresistant infections among returned Australian travellers Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea Rapidly growing Mycobacterium infections after cosmetic surgery in medical tourists: The Bronx experience and a review of the literature Do probiotics prevent colonization with multi-resistant Enterobacteriaceae during travel? A randomized controlled trial Traveler's diarrhea at sea: Three outbreaks of waterborne enterotoxigenic Escherichia coli on cruise ships Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States What were the risk factors and trends in antimicrobial resistance for enteric fever in London Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England Outbreak of NDM-1-producing Acinetobacter baumannii in France Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium MRSA infections in Norway: A study of the temporal evolution Laboratory based surveillance of travel-related Shigella sonnei and Shigella flexneri in Alberta from First international spread and dissemination of the virulent Queensland community-associated methicillin-resistant Staphylococcus aureus strain Ceftriaxone-resistant Salmonella enterica serotype Typhi in a pregnant traveller returning from Karachi High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; Prevalence study at a Norwegian hospital First Description of bla NDM-7 Carried on an IncX4 Plasmid in Escherichia coli ST679 Isolated in Spain Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin Severe infection with multidrugresistant Salmonella choleraesuis in a young patient with primary sclerosing cholangitis Bacterial Colonization of Patients Undergoing International Air Transport: A Prospective Epidemiologic Study Non-toxigenic penicillin-resistant cutaneous C. diphtheriae infection: A case report and review of the literature Prevalence and risk factors for Extended-Spectrum Beta-Lactamase-producing-Enterobacteriaceae in French military and civilian travelers: A cross-sectional analysis Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia Lactococcus garvieae multi-valve infective endocarditis in a traveler returning from South Korea Low Enteric Colonization with Multidrug-Resistant Pathogens in Soldiers Returning from Deployments-Experience from the Years Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States Vibrio cholerae in traveler from Haiti to Canada CTX-M-15-producing enteroaggregative Escherichia coli as cause of travelers' diarrhea Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland Laboratory-based surveillance of paratyphoid fever in the United States: Travel and antimicrobial resistance Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: Association of ciprofloxacin resistance to travel destination Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: Lessons from history Molecular characterization of multiresistant strains of Salmonella typhi from South Asia isolated in Ontario Isolation of OXA-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: The impact on clinical outcome and future treatment options Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers Characterization of Diarrheagenic Enteroaggregative Escherichia coli in Danish Adults-Antibiotic Treatment Does Not Reduce Duration of Diarrhea Characterization of isolates of Salmonella enterica serovar Stanley, a serovar endemic to Asia and associated with travel Genomic dissection of travel-associated extended-spectrum-beta-lactamase-producing Salmonella enterica serovar typhi isolates originating from the philippines: A one-off occurrence or a threat to effective treatment of typhoid fever? Plasmid-mediated quinolone resistance in different diarrheagenic Escherichia coli pathotypes responsible for complicated, noncomplicated, and traveler's diarrhea cases NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara Methicillin-resistant Staphylococcus aureus nasal carriage in international medical conference attendees Primary skin melioidosis in a returning traveler Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: An 18-year experience Multidrug-resistant Acinetobacter baumannii infections in three returning travelers evacuated from Algeria, Thailand, and Turkey after hospitalization in local intensive care units Multidrug-resistant tuberculous meningitis in a returned traveller Co-circulation of multidrug-resistant Shigella among men who have sex with men First outbreak of colonization by linezolid-and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii Characterization of Shigella sonnei isolates from travel-associated cases in Japan High prevalence of New Delhi metallo-b-lactamase-1 (NDM-1) producers among carbapenem-resistant Enterobacteriaceae in Kuwait Quinolone-resistant Shigella flexneri isolated in a patient who travelled to India Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa) Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis. Scand Multidrug-resistant bacteria among patients treated in foreign hospitals: Management considerations during medical repatriation Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE)-Data of prospective traveller study Plasmid-mediated quinolone resistance in human non-typhoidal Salmonella infections: An emerging public health problem in the United States Colonization with resistant microorganisms in patients transferred from abroad: Who needs to be screened? Fluoroquinolone-resistant Campylobacter infections: Eating poultry outside of the home and foreign travel are risk factors Patients hospitalized abroad as importers of multiresistant bacteria-A cross-sectional study Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam Fever and abdominal pain in a returning traveller Increase in the prevalence of Panton-Valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: A prospective, registered, multicentre study First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines Emergence of Carbapenemase-Producing Enterobacteriaceae Melioidosis acquired by a traveler from Papua New Guinea Analysis of Salmonella enterica serotype Typhi pulsed-field gel electrophoresis patterns associated with international travel Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients Travel Destinations and Sexual Behavior as Indicators of Antibiotic Resistant Shigella Strains-Victoria, Australia Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to Community-onset extended-spectrum b-lactamase (ESBL) producing Escherichia coli: Importance of international travel Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: A cross-sectional study International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin CTX-M-55-type extended-spectrum b-lactamaseproducing Shigella sonnei isolated from a Korean patient who had travelled to China Surveillance for travel and domestically acquired multidrug-resistant human Shigella infections-Pennsylvania Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers Complete sequence of an IncN plasmid, pIMP-HZ1, carrying bla IMP-4 in a Klebsiella pneumoniae strain associated with medical travel to China Colonization with extendedspectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany Extensivelydrug-resistant bacteria carriers among overseas travellers: One-third had not been hospitalized previously Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin Characterization of OXA-48-like carbapenemase producers in Canada Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with bla NDM-1 Arrives in North America Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India A large outbreak of Salmonella Paratyphi A infection among Israeli travelers to Nepal Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea Quinolone resistance among Shigella spp. isolated from travellers returning from India Typhoid fever in the United States, 1985-1994: Changing risks of international travel and increasing antimicrobial resistance Pet animals and foreign travel are risk factors for colonisation with extendedspectrum b-lactamase-producing Escherichia coli Canada's first case of a multi-drug resistant Corynebacterium diphtheriae, isolated from a skin abscess. Can Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller: Proposal for novel treatment indications Two for the price of one: Emerging carbapenemases in a returning traveller to Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe 12:i:-harbouring mcr-3.2 on a variant IncHI-2 plasmid identified in Canada Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents Influx of multidrug-resistant organisms by country-to-country transfer of patients Analysis of the mechanisms of resistance to several antimicrobial agents in Shigella spp. causing travellers' diarrhoea Molecular characterization of the integrons in Shigella strains isolated from patients with traveler's diarrhea Multidrug-resistant bacteria in travellers hospitalized abroad: Prevalence, characteristics, and influence on clinical outcome Genotypes and antibiotic resistances of Campylobacter jejuni and Campylobacter coli isolates from domestic and travel-associated human cases Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: A Swedish nationwide study Quinolone-resistant Salmonella enterica serotype EnteritiDis. infections associated with international travel Multidrug-resistant typhoid fever in Singapore Epidemiological approach to the prevention of imported infectious diseases in the age of globalization K1:H7 A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers on behalf of the Travel Study Group of Southeast Sweden. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: Incidence and risk factors Burkholderia pseudomallei infection in a child with cystic fibrosis: Acquisition in the Western Hemisphere Extendedspectrum b-lactamase-producing Enterobacteriaceae among travelers from the Netherlands Travelers' diarrhea in Nepal: An update on the pathogens and antibiotic resistance Shigella dysenteriae type 1 infections in US travellers to Mexico Imported enteric fever: Case series from the hospital for tropical diseases New Delhi metallo-b-lactamase from traveler returning to Canada Gut microbiota dynamics in travelers returning from India colonized with extended-spectrum cephalosporin-resistant Enterobacteriaceae: A longitudinal study Molecular characteristics of travel-related extendedspectrum-b-lactamase-producing Escherichia coli isolates from the Calgary Health Region Enteric fever among children: 50 cases in a French tertiary care centre Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): A retrospective analysis Imported typhoid fever with hepatitis from Bangladesh: A case of delayed response to ceftriaxone? The epidemiology of travelers' diarrhea in Incirlik, Turkey: A region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States Molecular Investigation of Carbapenem-Resistant Acinetobacter spp Potential international spread of multidrug-resistant invasive Salmonella enterica serovar enteritidis Treatment options for New Delhi metallo-beta-lactamase-harboring Enterobacteriaceae Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. Acta Pathologica Microbiologica Immunologica Scandinavica High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales Increase in paratyphoid fever cases in Japanese travellers returning from Cambodia in 2013 Extensively drug-resistant tuberculosis in a young child after travel to India Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway Acquisition and colonization dynamics of antimicrobial-resistant bacteria during international travel: A prospective cohort study Panton-Valentine leukocidin-producing methicillin-Sensitive Staphylococcus aureus as a cause for recurrent, contagious skin infections in young, healthy travelers returned from a tropical country: A new worldwide public health problem? Epidemiologic and genotypic review of carbapenemase-producing organisms in British Columbia Diversity of methicillin-resistant Staphylococcus aureus CC22-MRSA-IV from Saudi Arabia and the Gulf region Health risks encountered by Dutch medical students during an elective in the tropics and the quality and comprehensiveness of pre-and post-travel care Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites First Report and Molecular Characterization of a Campylobacter jejuni Isolate with Extensive Drug Resistance from a Travel-Associated Human Case Community-acquired methicillin-resistant Staphylococcus aureus in a returned traveler Whole genome sequencing of Salmonella Chester reveals geographically distinct clusters Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey Carrier prevalence and risk factors for colonisation of multiresistant bacteria in Danish emergency departments: A cross-sectional survey Extended spectrum b-lactamase-producing Escherichia coli faecal carriage in Spanish travellers returning from tropical and subtropical countries Imported methicillin-resistant Staphylococcus aureus International travel is a risk factor for extendedspectrum b-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan Fluoroquinolone-resistant and extendedspectrum β-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum b-lactamases: A prospective study with Swedish volunteers Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelers Travel-related Streptococcal Toxic Shock Syndrome caused by emm type 78 Streptococcus pyogenes Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype typhi Antimicrobial resistance of Shigella isolates in the USA: The importance of international travelers Antimicrobial resistance profiles of Shigella dysenteriae isolated from travellers returning to the UK Odenholt, I. Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei Enteric fever imported to the Czech Republic: Epidemiology, clinical characteristics and antimicrobial susceptibility Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections Proteus mirabilis harboring carbapenemase NDM-5 and ESBL VEB-6 detected in Austria CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives Antimicrobial resistance of Shigella isolates causing traveler's diarrhea Aeromonas spp. and traveler's diarrhea: Clinical features and antimicrobial resistance Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: Emergence of quinolone resistance Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers High rates of antimicrobial drug resistance gene acquisition after international travel A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: A molecular epidemiological study Carbapenem resistant Enterobacteriaceae carrying New Delhi metallo-b-lactamase gene (NDM-1) in Taiwan Kotter, I. Fatal multidrug-resistant Acinetobacter baumannii sepsis in a patient with travel history and recent onset of systemic lupus erythematosus: A case report Extended-spectrum β-lactamase-and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area A case of multi-drug resistant ESBL-producing Shigella sonnei acute acalculous cholecystitis and gastroenteritis in a returned traveller Increasing Antimicrobial Resistance in Nontyphoidal Salmonella Isolates in Australia from 1979 to Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece Epidemiology of extendedspectrum b-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonization Characterization of a new metallo-betalactamase gene, bla NDM-1 , and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India Human Movement and Transmission of Antimicrobial-Resistant Bacteria Diarrhea, Antibiotics, Antimicrobial Resistance and Practice Guidelines-A Holistic Approach to a Health Conundrum Gastrointestinal Infection Among International Travelers Globally Travellers' diarrhoea Mobile Genetic Elements Associated with Antimicrobial Resistance Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection Medical tourism today: What is the state of existing knowledge? United States Department of Transportation Research and Development Expenditure (% of GDP) We would like to thank Osamah Barasheed for his input in the initial database searching. The authors declare no conflict of interest.